0001104659-23-090706.txt : 20230811 0001104659-23-090706.hdr.sgml : 20230811 20230811211741 ACCESSION NUMBER: 0001104659-23-090706 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230809 FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vellanki Avanish CENTRAL INDEX KEY: 0001856682 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40356 FILM NUMBER: 231165893 MAIL ADDRESS: STREET 1: 8000 JARVIS AVENUE STREET 2: SUITE 204 CITY: NEWARK STATE: CA ZIP: 94560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rain Oncology Inc. CENTRAL INDEX KEY: 0001724979 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821130967 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 JARVIS AVENUE STREET 2: SUITE 204 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: (510) 953-5559 MAIL ADDRESS: STREET 1: 8000 JARVIS AVENUE STREET 2: SUITE 204 CITY: NEWARK STATE: CA ZIP: 94560 FORMER COMPANY: FORMER CONFORMED NAME: Rain Therapeutics Inc. DATE OF NAME CHANGE: 20171211 4 1 tm2323614-10_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-08-09 0 0001724979 Rain Oncology Inc. RAIN 0001856682 Vellanki Avanish C/O RAIN ONCOLOGY INC. 8000 JARVIS AVENUE, SUITE 204 NEWARK CA 94560 1 1 0 0 Chairman and CEO 0 Stock Option (Right to Buy) 1.21 2023-08-09 4 A 0 266500 0.00 A 2033-08-09 Common Stock 266500 266500 D Stock Option (Right to Buy) 1.21 2023-08-09 4 A 0 133250 0.00 A 2033-08-09 Common Stock 133250 133250 D This option represents a right to purchase a total of 266,500 shares of the Issuer's common stock, which will vest in equal installments on May 9, 2024 and February 9, 2025, subject to the Reporting Person's continued service to the Issuer. This option represents a right to purchase a total of 133,250 shares of the Issuer's common stock, which will vest in equal installments on May 9, 2024 and February 9, 2025, subject to the achievement of certain corporate goals and the Reporting Person's continued service to the Issuer. /s/ Avanish Vellanki 2023-08-11